Drugs / S.typhi
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03523767 | Feb 2018 → Feb 2020 | major depressive disorder | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S.typhi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03523767 ↗ |
| Modality | Vaccine | “typhoid vaccine injection” NCT03523767 ↗ |